GlassScriptPhysician profile
Gianmarco Paris
NPI 1821048133
$4,044.66
in general payments reported to CMS, 2019-2025
20 companies · $507 in 2025
The $507 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $389 · 2021: $392 · 2022: $613 · 2023: $334 · 2024: $1,314 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,600 · Travel and Lodging: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,600.23 |
| Travel and Lodging | $554.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,636.28 | 2019-2025 | Lensx, Clareon, Tryptyr |
| Abbvie INC. | $570.26 | 2022-2025 | |
| Allergan, INC. | $488.53 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $278.39 | 2022-2023 | Envista Mx60 Iol |
| Novartis Pharmaceuticals Corporation | $271.86 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $163.57 | 2019-2021 | |
| Amgen INC. | $119.70 | 2024-2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $86.64 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $80.26 | 2021-2023 | Tecnis Iol |
| Carl Zeiss Meditec USA, INC. | $46.53 | 2024 | |
| Thea Pharma INC. | $43.97 | 2024-2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.88 | 2020-2021 | |
| Oyster Point Pharma, INC. | $40.85 | 2022-2023 | Tyrvaya |
| Biotissue Holdings INC. | $34.72 | 2021-2022 | |
| New World Medical,INC. | $31.27 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $29.13 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $24.13 | 2025 | Xdemvy |
| Horizon Therapeutics Plc | $20.79 | 2021 | |
| Rxsight INC | $19.96 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $14.94 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gianmarco Paris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.